208 related articles for article (PubMed ID: 28099252)
1. The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study.
Saito T; Hirano K; Isayama H; Nakai Y; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Hamada T; Takahara N; Uchino R; Mizuno S; Kogure H; Matsubara S; Yamamoto N; Tada M; Koike K
Pancreas; 2017 Mar; 46(3):341-346. PubMed ID: 28099252
[TBL] [Abstract][Full Text] [Related]
2. A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer.
Saito T; Nakai Y; Isayama H; Hirano K; Ishigaki K; Hakuta R; Takeda T; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Takahara N; Hamada T; Uchino R; Mizuno S; Mouri D; Yagioka H; Kogure H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
Pancreas; 2018 Aug; 47(7):800-806. PubMed ID: 29851751
[TBL] [Abstract][Full Text] [Related]
3. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial.
Woo SM; Joo J; Kim SY; Park SJ; Han SS; Kim TH; Koh YH; Chung SH; Kim YH; Moon H; Hong EK; Lee WJ
Pancreatology; 2016; 16(6):1099-1105. PubMed ID: 27618657
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
7. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
8. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
[TBL] [Abstract][Full Text] [Related]
9. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
[TBL] [Abstract][Full Text] [Related]
10. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of pancreatic digestive enzymes alters the composition of intestinal microbiota in mice.
Nishiyama H; Nagai T; Kudo M; Okazaki Y; Azuma Y; Watanabe T; Goto S; Ogata H; Sakurai T
Biochem Biophys Res Commun; 2018 Jan; 495(1):273-279. PubMed ID: 29106956
[TBL] [Abstract][Full Text] [Related]
12. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
13. Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis.
van der Haak N; Boase J; Davidson G; Butler R; Miller M; Kaambwa B; Kritas S
J Cyst Fibros; 2016 Sep; 15(5):669-74. PubMed ID: 27102891
[TBL] [Abstract][Full Text] [Related]
14. Pancrelipase for pancreatic disorders: An update.
Dhanasekaran R; Toskes PP
Drugs Today (Barc); 2010 Nov; 46(11):855-66. PubMed ID: 21225024
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Function in Chronic Pancreatitis: A Cohort Study Comparing 3 Methods of Detecting Fat Malabsorption and the Impact of Short-term Pancreatic Enzyme Replacement Therapy.
Brownell JN; Schall JI; Stallings VA
Pancreas; 2019 Sep; 48(8):1068-1078. PubMed ID: 31404029
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
Roberts KJ; Bannister CA; Schrem H
Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
18. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
Satoi S; Sho M; Yanagimoto H; Yamamoto T; Akahori T; Kinoshita S; Nagai M; Hirooka S; Yamaki S; Nishiwada S; Ryota H; Ikeda N; Nakajima Y; Kon M
J Hepatobiliary Pancreat Sci; 2016 Mar; 23(3):167-73. PubMed ID: 26748629
[TBL] [Abstract][Full Text] [Related]
19. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
20. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
